Efficacy and Safety Study of Acetylcysteine/Doxofylline 1200/400 mg Effervescent Tablet in the Treatment of Moderate-Severe COPD.
Clinical trial NCT03388853 · COMPLETED
Trial details
- NCT number
- NCT03388853
- Sponsor
- Neutec Ar-Ge San ve Tic A.Ş
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-20
- Primary completion
- 2019-12-21
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.